Bruker Corporation (NASDAQ:BRKR) announced the results of its 2026 Annual Meeting of Stockholders. Shares trade at $44.98, up 24% over the past year, with the company valued at $6.84 billion. According to Bond.az analysis, the stock appears undervalued.
Stockholders elected three Class II directors: Laura A. Francis, John J. (Jack) Phillips, and Hermann F. Requardt, Ph.D., each serving until 2029.
In a separate advisory vote, stockholders approved 2025 executive compensation. PricewaterhouseCoopers LLP was ratified as independent auditor for fiscal year 2026.
Bruker is listed on Nasdaq under symbols BRKR (common stock) and BRKRP (preferred stock).












